Connect with us

Health

Common diabetes drug can reduce risk of major heart issues – TheHealthSite

SGLT2 inhibitors prescribed for diabetes can reduce the risk of heart conditions such as heart attack stroke and heart failure compared with placebo.

Published

on

post featured image
ADVERTISEMENT

Drugs known as sodium-glucose cotransporter 2 (SGLT2) inhibitors are associated with a lower risk of major heart problems in patients with type 2 diabetes than dipeptidyl peptidase-4 (DPP-4) inhibitors, say, researchers. According to the study, published in the journal The BMJ, previous trials have shown that SGLT2 inhibitors can reduce the risk of heart conditions such as heart attack, stroke, and heart failure compared with placebo. But some of these trials had important limitations, making it…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

post featured image
Toes discoloration … a new symptom of corona virus – AlKhaleej Today
Iraq reports 2,878 new COVID-19 cases, 470,633 in total – Xinhua | English.news.cn – Xinhua
post featured image
High rate of symptomless COVID-19 infection among grocery store workers: Those in customer-facing roles five times as likely to test positive as their colleagues – Science Daily